Posted 23 February, 2022
Blue Water Vaccines Inc. IPO completed
IPO completed detected for ticker Nasdaq:BWV in a 424B4 filed on 23 February, 2022.
This is the initial public offering of our common stock.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Blue Water Vaccines Inc.
Health Care/Life Sciences • Pharmaceuticals
Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH.Market Cap
$4.31M
View Company Details
$4.31M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.